Older women who take menopausal hormone therapy may be at a higher risk of Alzheimer's. A study published in Science Advances ...

For Alzheimer’s, blood tests for p-tau are still useful, but they should not be the only method for diagnosis. A positive ...

Researchers at Northwestern University have made a breakthrough in identifying a way for Alzheimer's disease to be treated ...

The results of a new study show that suppressing KCTD20, which responds to the neurotransmitter glutamate, activates a mechanism for expelling tau proteins.

"Studies have shown that vulnerability to Alzheimer's-related changes in the brain increase in women from pre- to ...

After Eli Lilly and Biogen’s setbacks in developing O-GlaNAcase (OGA) inhibitors for Alzheimer’s disease, Asceneuron has now ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...

Older women who underwent hormone replacement therapy during and after menopause had high markers associated with Alzheimer's ...

A special edition of the journal Science focuses on women's health, including links between estrogen and dementia, at a time ...

USC Stem Cell scientists discover a new way to rid cells of toxic tau protein in a study involving mice and lab-grown human ...

The neurotransmitter glutamate is essential for regulating everything from mood to memory, but it can also encourage a toxic ...

Diagnosing Alzheimer's disease before people have any symptoms is possible, but brings up concerns when so few treatments are ...